Treatment of Erectile Dysfunction in Males with Friedreich Ataxia

Erectile dysfunction is a recognised concern in males living with Friedreich ataxia. When a patient reports difficulty achieving or maintaining an erection in the context of this progressive neurological condition, a specific first-line pharmacological approach is indicated.

Clinical Scenario

This protocol addresses the male patient with Friedreich ataxia who presents with erectile dysfunction. The coexistence of this comorbidity warrants targeted management beyond general ataxia care.

Treatment Approach

Current evidence supports initiating a specific class of oral therapy directed at the vascular mechanism underlying erectile dysfunction in this population. The complete regimen — including agent selection, initiation criteria, and follow-up — is detailed in the full structured protocol.

Full regimen available via the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

We recommend commencing a phosphodiesterase-5 inhibitor in males with Friedreich ataxia who report erectile dysfunction.

DOI: 10.1186/s13023-022-02568-3

View source ↗